Atlas Trials

A Prospective Study Investigating the Relationship Between Minimal Residual Disease Detection, Monitoring Frequency, and Prognosis in Non-small Cell Lung Cancer Patients Eligible for Curative Treatment.

Clinical trial NCT06854939 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06854939
Sponsor
National Cancer Center, Japan
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
NSCLC, Stage I, II, III
Start date
2025-03-01
Primary completion
2026-09-30
Enrollment
350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.